NBIX Message Board Post 9196528 | Neurocrine Biosciences...
home / stock / nbix / nbix message board
radhika4435
(investorshub)
Posted on: May/02/2018 14:55:23
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140472995
107.20 is consensus target price and has the
News, Short Squeeze, Breakout and More Instantly...
Neurocrine Biosciences Inc. Company Name:
NBIX Stock Symbol:
Market:
Neurocrine Biosciences Inc. Website:
-
Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Applications and Grants Priority Review for Crinecerfont for Pediatric and Adult Patients with CAH PR Newswire PDUFA Target Action Dates in Late December 2024 Highly Selective CRF 1 Antagonist is the Potent...
-
Neurocrine Biosciences Presented CAHtalyst™ Phase 3 Pediatric and Adult Studies, CAHtalog™ Registry and Disease- and Glucocorticoid-Related Comorbidities Data in CAH at ENDO 2024 PR Newswire SAN DIEGO , June 3, 2024 /PRNewswire/ -- Neurocrine Bios...
-
Neurocrine Biosciences Announces Publication of Primary CAHtalyst™ Pediatric Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New England Journal of Medicine PR Newswire - CAHtalyst™ Pediatr...